Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Regional variations in physicians' attitudes and recommendations surrounding implantable cardioverter-defibrillators.

Matlock DD, Kutner JS, Emsermann CB, Al-Khatib SM, Sanders GD, Dickinson LM, Rumsfeld JS, Davidson AJ, Crane LA, Masoudi FA.

J Card Fail. 2011 Apr;17(4):318-24. doi: 10.1016/j.cardfail.2010.11.009. Epub 2011 Feb 22.

PMID:
21440870
2.

Physicians' knowledge and attitudes regarding implantable cardioverter-defibrillators.

Sherazi S, Zareba W, Daubert JP, McNitt S, Shah AH, Aktas MK, Block RC.

Cardiol J. 2010;17(3):267-73.

3.

Do physicians' attitudes toward implantable cardioverter defibrillator therapy vary by patient age, gender, or race?

Al-Khatib SM, Sanders GD, O'Brien SM, Matlock D, Zimmer LO, Masoudi FA, Peterson E.

Ann Noninvasive Electrocardiol. 2011 Jan;16(1):77-84. doi: 10.1111/j.1542-474X.2010.00412.x.

PMID:
21251138
4.

A national survey of clinician's knowledge of and attitudes towards implantable cardioverter defibrillators.

McHale B, Harding SA, Lever NA, Larsen PD.

Europace. 2009 Oct;11(10):1313-6. doi: 10.1093/europace/eup236. Epub 2009 Sep 3.

5.

Questionnaire survey of cardiologists' knowledge, attitudes, and guideline application of implantable cardioverter defibrillator therapy.

Sadarmin PP, Wong KC, Rajappan K, Bashir Y, Betts TR.

Pacing Clin Electrophysiol. 2012 Jun;35(6):672-80. doi: 10.1111/j.1540-8159.2012.03373.x. Epub 2012 Mar 27.

PMID:
22452348
6.

Racial disparity in the utilization of implantable-cardioverter defibrillators among patients with prior myocardial infarction and an ejection fraction of <or=35%.

Thomas KL, Al-Khatib SM, Kelsey RC 2nd, Bush H, Brosius L, Velazquez EJ, Peterson ED, Gilliam FR.

Am J Cardiol. 2007 Sep 15;100(6):924-9. Epub 2007 Jun 27.

PMID:
17826371
7.

Low referral pattern for implantable defibrillator therapy in a tertiary hospital: referral physician survey and Monte Carlo simulation.

Mohamad T, Jacob S, Kommuri NV, Modi S, Aravindhakshan R, Lieberman R.

Am J Ther. 2011 Sep;18(5):350-4. doi: 10.1097/MJT.0b013e3181d539e6.

PMID:
20335787
8.

Performing magnetic resonance imaging in patients with implantable pacemakers and defibrillators: results of a European Heart Rhythm Association survey.

Marinskis G, Bongiorni MG, Dagres N, Dobreanu D, Lewalter T, Blomström-Lundqvist C; Scientific Initiative Committee, European Heart Rhythm Association.

Europace. 2012 Dec;14(12):1807-9. doi: 10.1093/europace/eus379. Epub 2012 Nov 6.

9.

Use of implantable cardioverter defibrillator and cardiac resynchronization therapy: an Italian survey study on 220 cardiology departments.

Inama G, Pedrinazzi C, Landolina M, Oliva F, Senni M, Proclemer A, Berisso MZ, Pirelli S; ANMCO Arrhythmias, Heart Failure Areas.

J Cardiovasc Med (Hagerstown). 2012 Nov;13(11):675-83. doi: 10.2459/JCM.0b013e32834bd918.

PMID:
22002257
10.

Factors associated with improvement in guideline-based use of ICDs in eligible heart failure patients.

Mehra MR, Albert NM, Curtis AB, Gheorghiade M, Heywood JT, Liu Y, O'Connor CM, Reynolds D, Walsh MN, Yancy CW, Fonarow GC.

Pacing Clin Electrophysiol. 2012 Feb;35(2):135-45. doi: 10.1111/j.1540-8159.2011.03279.x. Epub 2011 Dec 6.

PMID:
22145695
11.

A Comparison of ICD implantations in the United States versus Italy.

Greenberg SM, Epstein AE, Deering T, Goldman DS, Ghidina M, Neason C, Proclemer A.

Pacing Clin Electrophysiol. 2007 Jan;30 Suppl 1:S143-6. Erratum in: Pacing Clin Electrophysiol. 2007 Nov;30(11):1427.

PMID:
17302692
12.

Referring physicians' discordance with the primary prevention implantable cardioverter-defibrillator guidelines: a national survey.

Castellanos JM, Smith LM, Varosy PD, Dehlendorf C, Marcus GM.

Heart Rhythm. 2012 Jun;9(6):874-81. doi: 10.1016/j.hrthm.2012.01.029. Epub 2012 Feb 2.

13.

[Spanish Implantable Cardioverter-Defibrillator Registry. Third Official Report of the Spanish Society of Cardiology Working Group on Implantable Cardioverter-Defibrillators (2006)].

Peinado R, Torrecilla EG, Ormaetxe J, Alvarez M; Grupo de Trabajo de Desfibrilador Implantable.

Rev Esp Cardiol. 2007 Dec;60(12):1290-301. Spanish.

14.

A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.

Buxton M, Caine N, Chase D, Connelly D, Grace A, Jackson C, Parkes J, Sharples L.

Health Technol Assess. 2006 Aug;10(27):iii-iv, ix-xi, 1-164. Review.

15.

[Spanish registry of implantable cardioverter defibrillator. Second official report of the Spanish Society of Cardiology Working Group on Implantable Cardioverter Defibrillators (2005)].

Peinado R, Torrecilla EG, Ormaetxe J, Alvarez M; Spanish Society of Cardiology Working Group on Implantable Cardioverter Defibrillators.

Rev Esp Cardiol. 2006 Dec;59(12):1292-302. Spanish.

16.

Physicians' preferences and attitudes about end-of-life care in patients with an implantable cardioverter-defibrillator.

Sherazi S, Daubert JP, Block RC, Jeevanantham V, Abdel-Gadir K, DiSalle MR, Haley JM, Shah AH.

Mayo Clin Proc. 2008 Oct;83(10):1139-41. doi: 10.4065/83.10.1139.

PMID:
18828973
17.

Exploration of physicians' recommendations for activities in chronic low back pain.

Rainville J, Carlson N, Polatin P, Gatchel RJ, Indahl A.

Spine (Phila Pa 1976). 2000 Sep 1;25(17):2210-20.

PMID:
10973405
18.

Ethical and legal views of physicians regarding deactivation of cardiac implantable electrical devices: a quantitative assessment.

Kramer DB, Kesselheim AS, Brock DW, Maisel WH.

Heart Rhythm. 2010 Nov;7(11):1537-42. doi: 10.1016/j.hrthm.2010.07.018. Epub 2010 Jul 19.

19.

[Spanish implantable cardioverter-defibrillator registry. First official report of the spanish society of cardiology working group on implantable cardioverter-defibrillators (2002-2004)].

Peinado R, Arenal A, Arribas F, Torrecilla E, Alvarez M, Ormaetxe JM, Pérez-Castellano N.

Rev Esp Cardiol. 2005 Dec;58(12):1435-49. Spanish.

20.

Evidence of clinical practice heterogeneity in the use of implantable cardioverter-defibrillators in heart failure and post-myocardial infarction left ventricular dysfunction: Findings from IMPROVE HF.

Mehra MR, Yancy CW, Albert NM, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, McBride ML, O'Connor CM, Reynolds D, Walsh MN, Fonarow GC.

Heart Rhythm. 2009 Dec;6(12):1727-34. doi: 10.1016/j.hrthm.2009.08.022. Epub 2009 Aug 22.

PMID:
19959119
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk